Rafiqul Hussain

Rafiqul Hussain

Auto-generated profile, based on publicly available information

Rafiqul Hussain

Affiliation Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
CCClaudia Calabrese
Claudia Calabrese
APAngela Pyle
Angela Pyle
HGHelen Griffin
Helen Griffin
JCJonathan Coxhead
Jonathan Coxhead
RHRafiqul Hussain
Rafiqul Hussain
PCPatrick F. Chinnery
Patrick F. Chinnery
Mitochondria are implicated in the pathogenesis of cardiovascular diseases (CVDs) but the reasons for this are not well understood. Maternally-inherited population variants of mitochondrial DNA (mtDNA) which affect all mtDNA molecules (homoplasmic) are associated with cardiometabolic traits and the risk of developing cardiovascular disease. However, it is not known whether mtDNA mutations only affecting a proportion of mtDNA molecules (heteroplasmic) also play a role. To address this question, we performed a high-depth (~1000-fold) mtDNA sequencing of blood DNA in 1,399 individuals with hypertension (HTN), 1,946 with ischemic heart disease (IHD), 2,146 with ischemic stroke (IS), and 723 healthy controls. We show that the per individual burden of heteroplasmic single nucleotide variants (mtSNVs) increases with age. The age-effect was stronger for low-level heteroplasmies (heteroplasmic fraction, HF, 5–10%), likely reflecting acquired somatic events based on trinucleotide mutational signatures. After correcting for age and other confounders, intermediate heteroplasmies (HF 10–95%) were more common in hypertension, particularly involving non-synonymous variants altering the amino acid sequence of essential respiratory chain proteins. These findings raise the possibility that heteroplasmic mtSNVs play a role in the pathophysiology of hypertension.

22 October 2025 in bioRxiv
Verified
Preprint
Open access
NSNeha Shaikh
Neha Shaikh
MTMatthew Teasdale
Matthew Teasdale
LWLewis J Walker
Lewis J Walker
LWLaura Wilson
Laura Wilson
RHRachel Howarth
Rachel Howarth
ABAdriana G. B. Buskin
Adriana G. B. Buskin
Current prostate organoid models rely on tissue-derived material or animal components and lack epithelial and stromal complexity. We defined a xeno-free system to generate human prostate organoids from induced pluripotent stem cells with consistent multilineage differentiation. Floating organoids self-organize into epithelial and stromal domains with basal, luminal, neuroendocrine, fibroblast, and smooth muscle markers. In an alternative modular co-culture system, engineered epithelial progenitors are aggregated with wild-type mesenchymal progenitors, enabling compartment-specific manipulation. Androgen receptor–overexpressing organoids showed increased epithelial AR and PSA expression and proliferation. Single-cell transcriptomics, together with qPCR and immunostaining, confirmed prostate lineage specification and tissue organization. This new xeno-free platform provides a reproducible, scalable, and genetically tractable model to study in-vitro prostate lineage programs, epithelial-stromal interactions, and disease biology. Graphic This study describes the generation of prostate organoids from human iPSCs. iPSCs, including those reprogrammed from patients carrying germline mutations, can be differentiated into prostate organoids either through monoculture or by co-culturing endodermal cells with mesenchymal progenitors. Genetic manipulation can be introduced before endoderm specification to model cancer drivers. The resulting multi-lineage organoids exhibit distinct epithelial (AR⁺, NKX3.1⁺, PSA⁺, CK8/18⁺) and stromal (VIM⁺, α-SMA⁺) compartments, providing a versatile platform for developmental studies, disease modelling, drug screening, and biomarker discovery.